Akebia Therapeutics(DE:AX9)
€0.37+0.00 (+0.83%)
DE:AX9
Akebia Therapeutics earnings date
€0.37
At close:+0.00 (+0.83%)
Akebia Therapeutics (AX9) Q2 2024 Earnings Report
2 Followers
DE:AX9 Q2 2024 EPS Results
- Actual EPS
- -EUR 0.04
- Consensus EPS
- -EUR 0.07
- Beat/Miss
- Beat by +EUR 0.03
- One Year Ago EPS
- -EUR 0.05
DE:AX9 Q2 2024 Revenue Results
- Actual Revenue
- EUR 39.60M
- Expected Revenue
- EUR 45.18M
- Beat/Miss
- Missed by -EUR 5.58M
- YoY Revenue Growth
- -22.58%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/08/2024
- Time
- Before Open
- Conference Call
- Thursday, August 8, 2024
DE:AX9 Upcoming Earnings
Akebia Therapeutics's next earnings date is estimated for March 3, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
DE:AX9 Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:AX9 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 03, 2027 | 2026 (Q4) | -0.06- | -0.05 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.03-0.05 | 0 | ― | |
| Aug 05, 2026 | 2026 (Q2) | -0.04-0.03 | 0 | ― | |
| May 07, 2026 | 2026 (Q1) | -0.03-0.03 | 0.03 | -200.00% (-0.05) | |
| Feb 26, 2026 | 2025 (Q4) | -0.03-0.05 | -0.09 | 50.00% (+0.05) | |
| Nov 10, 2025 | 2025 (Q3) | -0.010.00 | -0.09 | 100.00% (+0.09) | |
| Aug 07, 2025 | 2025 (Q2) | -0.010.00 | -0.04 | 100.00% (+0.04) | |
| May 08, 2025 | 2025 (Q1) | -0.030.03 | -0.08 | 133.33% (+0.11) | |
| Mar 13, 2025 | 2024 (Q4) | -0.07-0.09 | 0 | ― | |
| Nov 07, 2024 | 2024 (Q3) | -0.06-0.09 | -0.07 | -25.00% (-0.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

